Send us Feedback

Sequenom (SQNM)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

SQNM » Topics » COMPENSATION COMMITTEE REPORT *

This excerpt taken from the SQNM DEF 14A filed Apr 8, 2009.

COMPENSATION COMMITTEE REPORT*

The Compensation Committee has reviewed and discussed with management the Compensation Discussion and Analysis contained in this proxy statement. Based on the review and discussion, the Compensation Committee has recommended to our Board of Directors that the Compensation Discussion and Analysis be included in this proxy statement and incorporated into our Annual Report on Form 10-K for the fiscal year ended December 31, 2008.

This excerpt taken from the SQNM DEF 14A filed May 11, 2007.

COMPENSATION COMMITTEE REPORT *

The Compensation Committee has reviewed and discussed with management the Compensation Discussion and Analysis contained in this proxy statement. Based on the review and discussion, the Compensation Committee has recommended to our Board of Directors that the Compensation Discussion and Analysis be included in this proxy statement and incorporated into our Annual Report on Form 10-K for the fiscal year ended December 31, 2006, as amended.

EXCERPTS ON THIS PAGE:

DEF 14A
Apr 8, 2009
DEF 14A
May 11, 2007

RELATED TOPICS for SQNM:

"COMPENSATION COMMITTEE REPORT *" elsewhere:

Acorda Therapeutics (ACOR)
Affymetrix (AFFX)
Affymax (AFFY)
Anika Therapeutics (ANIK)
American Oriental Bioengineering (AOB)
Cadence Pharmaceuticals (CADX)
Cambrex (CBM)
Cerus (CERS)
Dendreon (DNDN)
Dyax (DYAX)
Emergent Biosolutions (EBS)
Halozyme Therapeutics (HALO)
Heska (HSKA)
Endo Pharmaceuticals Solutions Inc. (IDEV)
Idenix Pharmaceuticals (IDIX)
Illumina (ILMN)
ImmunoGen (IMGN)
Incyte (INCY)
InterMune (ITMN)
Medivation (MDVN)
Medarex (MEDX)
Neurocrine Biosciences (NBIX)
NPS Pharmaceuticals (NPSP)
ARCA biopharma, Inc. (NUVO)
Omrix Biopharmaceuticals (OMRI)
Optimer Pharmaceuticals (OPTR)
OSI Pharmaceuticals (OSIP)
Protalix BioTherapeutics (PLX)
Questcor Pharmaceuticals (QSC)
Seattle Genetics (SGEN)
Tercica (TRCA)
Targacept (TRGT)
Vanda Pharmaceuticals (VNDA)
ZymoGenetics (ZGEN)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki